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Parathyroid carcinoma (PC) is a rare endocrine malignancy. The tumor is mostly functioning, causing severe primary
hyperparathyroidism, with high serum calcium and parathyroid hormone (PTH) levels. Nonfunctioning PC is extremely
rare. We report a 50-year-old male patient who was referred to our Department for a right thyroid nodule, incidentally
detected on carotid Doppler ultrasound scan, with a fine-needle aspiration cytology showing a follicular lesion. At the
time of our evaluation, neck ultrasound showed a 1.3 cm right hypoechoic thyroid nodule with irregular margins and
the absence of enlarged bilateral cervical lymph nodes. Thyroid function tests were normal. Serum calcium was normal
and plasma PTH slightly above the upper limit of the normal range. The patients underwent right lobectomy. The
intraoperative frozen-section pathological examination raised the suspicion of a PC. Definitive histology showed a
markedly irregular infiltrative growth of the tumor with invasion of the thyroid tissue and cervical soft tissues.
Immunostaining for thyroglobulin was negative, whereas staining for chromogranin A and PTH showed a strong
reactivity. Based on the microscopic findings and the immunohistochemical profile, the tumor was diagnosed as
a PC. Postoperative serum calcium and phosphate levels were in the normal range. One month after surgery,
serum calcium and PTH were normal. Neck ultrasound and total body computed tomography scan were negative for
local and metastatic disease. Eight months later, serum calcium was normal and plasma PTH level remained
around the upper limit of normal range. Neck ultrasound did not show any pathological lesions. This is the first
case of a nonfunctioning sporadic PC misdiagnosed prior of surgery as a follicular thyroid nodule. The parathyroid
nature of the neck lesion could not be suspected before surgery. Fine-needle aspiration cytology (FNAC) may fail to
distinguish a parathyroid tumor from a benign thyroid nodule because at FNAC, parathyroid and thyroid lesions have
some morphological similarities. Histological criteria are not always sufficient for the differential diagnosis, which can
definitely be established using immunohistochemistry.
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Parathyroid carcinoma (PC) is a rare disease accounting
for less than <1 % of cases of primary hyperparathyroid-
ism (PHPT) [1, 2]. PC is usually a sporadic disease, but
it has also been reported in familial PHPT, namely the
hyperparathyroidism-jaw tumor syndrome (HPT-JT) and,
very rarely, in the multiple endocrine neoplasia type 1
(MEN1) [3]. At variance with the asymptomatic benign
counterpart, patients with PC usually present markedly el-
evated serum calcium and parathyroid hormone (PTH)
levels [4, 2]. The clinical features are mostly due to the* Correspondence: cetani@endoc.med.unipi.it
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article, unless otherwise stated.effects of the excessive secretion of PTH by the function-
ing tumor rather than to the spread of tumor mass. The
management of PC is primarily surgical, with en bloc re-
section of the tumor with involved adjacent structures [5,
4]. Rarely, parathyroid PC has been described in patients
with normal levels of serum calcium and PTH (nonfunc-
tioning PC) [6, 7] and, with the exception of one case
in the setting of MEN-2A [8], all cases reported so far
are sporadic [7]. The diagnosis of nonfunctioning PC
has always been established at histology. Indeed, in the
absence of hypercalcemia, the parathyroid origin of the
neck lump cannot be established, and the lesion is usually
diagnosed as thyroid or thymic carcinoma, because ofe is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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hoarseness due to laryngeal nerve palsy).
The suspicion of the parathyroid origin of the excised
tumor may raised by the finding at histology of feature
suggestive of PC, namely uniform sheets of cells arranged
in a lobular pattern separated by dense fibrous trabeculae,
mitotic figures within tumor parenchymal, full thickness
capsular invasion with growth into adjacent tissues, and
extratumoral vascular invasion [9, 10]. Nevertheless,
immunohistochemical studies for PTH, thyroglobulin,
thyroid transcription factor 1, and calcitonin are usually
performed to establish the definitive diagnosis.
Tumor resection is rarely curative and patients mostly
die for the local invasion.
Case presentation
Written informed consent was obtained from the patient
for the publication of the case report and any accom-
panying images.
A 50-year-old male patient was admitted to our De-
partment for a thyroid nodule on the right side of the
neck, which was incidentally detected on carotid Dop-
pler ultrasound scan. Fine-needle aspiration cytology
(FNAC) showed a follicular lesion. At the time of our
evaluation, the patient was in good health. The medical
history revealed hypertension, vitiligo, and celiac disease.Fig. 1 Cytological and histological specimens of nonfunctioning parathyro
organized in small cohesive clusters resembling thyroid microfollicles (Papa
showing the neoplastic invasion of the neighboring thyroid tissue (arrows
magnification). c Histological section showing the neoplastic invasion of th
tissue; hematoxylin- and eosin-stain, ×2 original magnification). d–f Immun
parathyroid tumor to thyroglobulin ((d), ×4 original magnification) and strong
and parathyroid hormone (f), ×4 original magnification)On physical examination, a small nodule (1 cm) was palp-
able in the right thyroid lobe. No enlarged neck lymph
nodes were palpable. Neck ultrasound showed a 1.3 cm
hypoechoic nodule with irregular margins in the right
thyroid lobe together with bilateral small thyroid nodules
(4–5 mm) and the absence of enlarged cervical bilateral
lymph nodes. Thyroid function tests were normal with the
absence of thyroid autoantibodies. Serum calcium was
normal (9.7 mg/dl; normal range, 8.4–10.4 mg/dL) and
PTH, routinely measured together with serum calcium in
our Center in patients undergoing thyroid surgery, slightly
elevated (68 pg/mL (intact PTH, 2nd generation assay;
normal range, 10–65 pg/mL)). The re-review of the ori-
ginal slides of FNAC confirmed a follicular lesion. In
particular, the cytology of the nodule showed epithelial
cells with hyperchromatic nuclei organized in small cohe-
sive clusters resembling microfollicles typically observed
in thyroid follicular lesions were evident (Fig. 1a).
The patients underwent right lobectomy. During neck
exploration, there were no macroscopic signs of local
invasion. The intraoperative frozen-section pathological
examination raised the suspicion of a PC. Definitive
histology showed a markedly irregular infiltrative growth
of the tumor with invasion of the thyroid tissue and cer-
vical soft tissues (Fig. 1b, c). Immunostaining for thyro-
globulin was negative, whereas staining for chromograninid carcinoma. a Cytological specimen showing epithelial cells
nicolaou-stain, ×40 original magnification). b Histological section
indicate the thyroid tissue; hematoxylin- and eosin-stain, ×2 original
e soft tissue surrounding the parathyroid tumor (*indicates the soft
ohistochemical stainings showing absence of immunoreactivity of the
immunoreactivity to Chromogranin A ((e), ×4 original magnification)
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on the light microscopic findings and the immunohisto-
chemical profile, the tumor was diagnosed as a PC.
Postoperative serum calcium (8.7 mg/dl) and phosphate
(3 mg/dl) levels were in the normal range. One month
after surgery, serum calcium and plasma PTH were
9.6 mg/dL and 47 pg/mL, respectively. Neck ultrasound
and total body computed tomography scan were negative
for local and metastatic disease. Eight months later, serum
calcium and plasma PTH levels were 9.1–9.2 mg/dl and
38–44 pg/ml (1–84 PTH 3rd generation assay, normal
range, 8–40 pg/mL), respectively. Neck ultrasound did not
show any pathological lesions. In order to exclude a familiar
form of PHPT, in which PC may rarely occur as a nonfunc-
tioning tumor [11], the screening of serum calcium and
neck ultrasound in the first-degree relatives was normal.
Discussion
We describe a patient with a thyroid nodule discovered
at carotid ultrasound, which underwent a routine diagnos-
tic workout, which showed typical ultrasound features and
cytological evidence of a follicular thyroid lesion. Surpris-
ingly, the histological diagnosis revealed a PC.
In experienced hand, neck ultrasound has a high sensitiv-
ity in recognizing a eutopic parathyroid lesion, but it may
fail when it has an ectopic location or is located within the
thyroid [12, 13]. The latter condition occurred in the
patient described herein as well as in the patient described
by Kim et al., who reported a 53-year-old woman with a be-
nign thyroid nodule at neck ultrasound, initially treated
elsewhere with radiofrequency ablation, which was subse-
quently found to be a parathyroid adenoma at surgery [14].
FNAC may also fail to distinguish a parathyroid tumor
from a benign thyroid nodule because at FNAC parathy-
roid and thyroid lesions have some morphological simi-
larities [15]. Indeed, colloids and macrophages, which
generally are found in a thyroid nodule, can be also be
present in a parathyroid lesion. On the hand, parathyroid
cells are generally smaller than thyroid cells and have less
cytoplasm and more chromatin, but these are not a
specific signs [16].
At surgery, the intraoperative frozen-section pathology
in our patient suggested that the excised lesion was a PC
and not a thyroid lesion. Despite this unexpected finding,
the surgical procedure was limited to the right lobectomy
because the surgeon could not find any macroscopic
infiltration and/or enlarged lymph nodes. The diagno-
sis of a PC was confirmed by definitive histology and
immunohistochemistry.
To our knowledge, this is the first case of a nonfunc-
tioning sporadic PC misdiagnosed prior of surgery as a
follicular thyroid nodule. The parathyroid nature of the
neck lesion could not be suspected before surgery. Indeed,
serum calcium concentration was normal and PTH slightlyabove the upper limit of the normal range. In interpreting
this latter finding, we should keep in mind that the upper
normal limit is usually fixed at the 97.5 percentile of the
distribution of PTH among normal individuals; therefore,
some normal individuals may have slightly elevated PTH.
Another explanation could be that the slight increase of
PTH level could be due to a low vitamin D status, which is
a rather common condition [17]. Other secondary causes
of elevation of PTH, namely thiazides diuretic use and
reduced renal function, were excluded. The finding that
plasma PTH remained around the upper limit of normal
range following parathyroidectomy supports the concept
that the parathyroid tumor was nonfunctioning.
The immunohistochemical finding of PTH protein in
the tumor confirms its parathyroid origin as well as its
ability to transcribe the PTH mRNA. The question of
whether an active PTH molecule is synthesized but not
secreted or whether the PTH molecule detected at im-
munostaining is not the mature form of PTH, which
even if secreted cannot be measured in the serum, cannot
be established. Unfortunately, we do not have fresh-frozen
tissue for mRNA analysis nor preoperative serum/plasma
samples to further investigate these possibilities. The
patient described by Baba et al. may help to shed light
on this matter [18]. These authors reported a patient
with classical hypercalcemic PC, in whom 2 years after
parathyroidectomy, a large supraclavicular mass was de-
tected. The patient had normal serum calcium and PTH.
The lesion was excised and a recurrent, apparently
nonfunctioning PC was diagnosed at histology. The pa-
tient developed transient hypocalcemia after surgery. PTH
mRNA was detected in the tumor. The absence of hyper-
calcemia suggested that the recurrence was nonfunction-
ing. The authors concluded that the identification of PTH
mRNA in the tumor as well as the transient hypocalcemia
after surgery suggest that PTH was synthesized and
secreted, albeit in amounts too small to cause hyper-
calcemia, but sufficient to cause suppression of the pre-
sumably normal parathyroid glands [18]. At variance with
this case, our patient did not show postoperative hypocal-
cemia, further supporting that the tumor did not secrete
full-length PTH.
Nonfunctioning PC is diagnosed in most patients in
the sixth or seventh decade (age range 27–71 years) [7,
19]. The tumor size is variable but ranges between 5 and
11 cm, and in almost half of the cases, loco regional
spread into thyroid, cervical soft tissues and superior
mediastinum is usually present at diagnosis [7, 19]. At
variance, in our patient, the diagnosis was done at an
earlier age (50 years) and the tumor size was 13 mm,
likely because the patient was submitted to surgery for a
follicular thyroid lesion.
The histological diagnosis of PC is currently restricted
to lesions showing unequivocal extra-parathyroidal growth,
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invasion with growth into adjacent tissues, extratumoral
vascular invasion, or metastasis. The histological criteria
were all present in the tumor of our patient [9]. Several
immunohistochemical markers have been evaluated to
further improve the diagnostic accuracy of a nonfunc-
tioning PC [20, 21]. Positive staining of chromogranin A
and synaptophysin and negative staining of thyroglobulin
has been reported in nonfunctioning PC [21, 20, 22]. In
our case, a positive staining for PTH and chromogranin
A, and negative staining for thyroglobulin, confirmed
the parathyroid nature of the tumor. Therefore, the ac-
curate diagnosis of nonfunctioning PC should be made
by considering the combination of clinical presenta-
tions, tissue morphologic structure, and immunohisto-
logical staining.
Limited information is available on the follow-up of
patients with nonfunctioning PC. Recurrences occurred
in about half of the patients (7), but the majority (about
80 %) was alive when reported in the literature, even
though the follow-up was rather short; only four patients
were followed for more than 5 years after the initial sur-
gery [7, 19]. Long-term follow-up data and information
on mortality are not available, but the advance stage of
the PC at diagnosis likely predict a poor prognosis,
worse than that of patients with classical hypercalcemic
PC, in whom the disease extension is more limited at
time of diagnosis (metastases to lymph nodes (<5 %) or
distant sites (<2 %)) [2, 23]. Even though during the
follow-up, the tumor usually spreads to cervical nodes
(30 %) and lung (40 %) and less frequently to liver and
bone (10 %); the overall survival is of about 72 and 50 %
at 5 and 10 years, respectively [23, 6].Conclusions
This is the first case of a nonfunctioning sporadic PC
misdiagnosed prior of surgery as a follicular thyroid nodule.
The parathyroid nature of the neck lesion could not be
suspected before surgery. FNAC may fail to distinguish
a parathyroid tumor from a benign thyroid nodule because
at FNAC, parathyroid and thyroid lesions have some
morphological similarities. Histological criteria are not
always sufficient for the differential diagnosis, which
can definitely be established using immunohistochemistry.
The reported case may likely contribute to enlarge the
expanding clinical spectrum of nonfunctioning PC.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for review
by the Editor of this journal.Abbreviations
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